CORRESP Filing
Solana Co
Date: May 28, 2025 · CIK: 0001610853 · Accession: 0001104659-25-053350
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-287572
Letter
Re: Helius Medical Technologies, Inc.
May 28, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1
File No. 333-287572
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group LLC ("Maxim"), as placement agent, hereby concurs in the request of Helius Medical Technologies, Inc. that the effective date of the above-referenced Registration Statement be accelerated to 5:00 PM, Eastern Time, on Thursday, May 29, 2025, or as soon thereafter as may be practicable.
Maxim affirms that it is aware of its obligations under the Securities Act in connection with this offering.
Very truly yours,
Maxim Group LLC
Show Raw Text
CORRESP
1
filename1.htm
May 28, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Helius Medical Technologies, Inc.
Registration Statement on Form S-1
File No. 333-287572
Ladies and Gentlemen:
Pursuant to Rule 461 of the General
Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended, Maxim Group
LLC ("Maxim"), as placement agent, hereby concurs in the request of Helius Medical Technologies, Inc. that the
effective date of the above-referenced Registration Statement be accelerated to 5:00 PM, Eastern Time, on Thursday, May 29,
2025, or as soon thereafter as may be practicable.
Maxim affirms that it is aware
of its obligations under the Securities Act in connection with this offering.
Very truly yours,
Maxim Group LLC
By:
/s/
Ritesh Veera
Name: Ritesh Veera
Title: Co-Head of Investment Banking